Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 4/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL956925 | 0.82 | ALDH1A1 (0.31) | CYP17A1CYP19A1ALDH1A1GAAKDM4E | |
| SCHEMBL957486 | 0.79 | ALDH1A1 (0.39) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL1398375 | 0.77 | ALDH1A1 (0.37) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL953661 | 0.76 | KDM4E (0.35) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL956923 | 0.76 | ALDH1A1 (0.39) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL955212 | 0.74 | CYP17A1 (0.36) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL24361043 | 0.72 | CYP17A1 (0.41) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL955213 | 0.71 | ALDH1A1 (0.36) | CYP17A1CYP19A1RECQLALDH1A1GAA | |
| SCHEMBL957911 | 0.71 | MEN1 (0.36) | CYP17A1CYP19A1ALDH1A1GAAKDM4E | |
| SCHEMBL1462092 | 0.71 | CYP17A1 (0.40) | CYP17A1CYP19A1RECQLALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8609889-B2 | Photoacid generator, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-12-17 | — | — | US | disclosed |
| US-20110003247-A1 | PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003247-A1 | PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS | GRHPR, GLRA3, GLRA1 | CYP17A1 2703/4885CYP19A1 2427/4885RECQL 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.